Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
HPV-16 E7 by Gilead Sciences for Oropharyngeal Cancer: Likelihood of Approval
HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Oropharyngeal Cancer. According to GlobalData,...
Data Insights
HPV-16 E7 by Gilead Sciences for Human Papillomavirus (HPV) Associated Cancer: Likelihood of Approval
HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer....